Article Details

Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $53.00

Retrieved on: 2021-02-02 10:51:00

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $53.00. View article details on hiswai:

Excerpt

WINTON GROUP Ltd bought a new position in shares of Rhythm Pharmaceuticals during the third quarter worth approximately $285,000. Finally ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up